HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Giorgio Gandaglia Selected Research
Giorgio Gandaglia Research Topics
Disease
220
Prostatic Neoplasms (Prostate Cancer)
04/2024 - 02/2012
75
Neoplasms (Cancer)
04/2024 - 01/2014
35
Urinary Bladder Neoplasms (Bladder Cancer)
03/2024 - 01/2014
32
Neoplasm Metastasis (Metastasis)
02/2024 - 10/2016
12
Carcinoma (Carcinomatosis)
03/2024 - 03/2014
11
Margins of Excision
12/2023 - 03/2014
6
Erectile Dysfunction
01/2021 - 05/2013
5
Renal Cell Carcinoma (Grawitz Tumor)
04/2024 - 01/2014
5
Urinary Incontinence
11/2023 - 05/2013
5
Lymphatic Metastasis
01/2023 - 02/2016
5
Lower Urinary Tract Symptoms
04/2022 - 09/2015
4
Acute Kidney Injury (Acute Renal Failure)
03/2015 - 08/2014
3
Disease Progression
10/2023 - 12/2013
3
Non-Muscle Invasive Bladder Neoplasms
10/2023 - 04/2016
3
Lymphadenopathy
09/2023 - 02/2016
3
Pain (Aches)
04/2023 - 01/2016
3
Pathologic Constriction (Stenosis)
10/2019 - 01/2017
3
Infections
11/2017 - 03/2015
3
Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2017 - 09/2015
3
Cardiovascular Diseases (Cardiovascular Disease)
01/2016 - 05/2014
2
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2023 - 03/2021
2
Lymphocele
01/2021 - 01/2017
2
Urologic Neoplasms (Urological Cancer)
01/2017 - 12/2014
2
Coronary Artery Disease (Coronary Atherosclerosis)
12/2014 - 05/2014
2
Myocardial Infarction
12/2014 - 12/2014
2
Inflammation (Inflammations)
05/2014 - 08/2013
1
Kidney Neoplasms (Kidney Cancer)
04/2024
1
Transitional Cell Carcinoma
04/2024
1
Intraoperative Complications
12/2023
1
Extranodal Extension
05/2023
1
Fatigue
04/2023
1
Noninfiltrating Intraductal Carcinoma (DCIS)
01/2023
1
Adenocarcinoma
01/2023
Drug/Important Bio-Agent (IBA)
26
Androgens
IBA
08/2023 - 05/2014
24
Prostate-Specific Antigen (Semenogelase)
IBA
11/2023 - 03/2014
18
Antigens
IBA
12/2023 - 08/2020
16
Hormones (Hormone)
IBA
12/2023 - 05/2015
9
pembrolizumab
IBA
12/2021 - 01/2020
8
Biomarkers (Surrogate Marker)
IBA
08/2023 - 08/2013
6
Docetaxel (Taxotere)
FDA Link
12/2023 - 01/2018
4
Androgen Receptors (Androgen Receptor)
IBA
04/2023 - 05/2019
4
enzalutamide
IBA
04/2023 - 01/2018
3
Indicators and Reagents (Reagents)
IBA
01/2023 - 01/2016
3
gallium 68 PSMA-11
IBA
11/2022 - 08/2020
3
Testosterone (Sustanon)
FDA Link
01/2017 - 12/2014
3
Phosphodiesterase 5 Inhibitors
IBA
01/2016 - 05/2014
3
Gonadotropin-Releasing Hormone (GnRH)
FDA Link
12/2014 - 08/2014
2
Immune Checkpoint Inhibitors
IBA
04/2024 - 10/2021
2
Lutetium-177
IBA
08/2023 - 01/2022
2
darolutamide
IBA
04/2023 - 12/2022
2
apalutamide
IBA
04/2023 - 12/2022
2
Abiraterone Acetate
IBA
12/2022 - 01/2021
2
RNA (Ribonucleic Acid)
IBA
12/2021 - 01/2020
1
Immunoconjugates (Immunoconjugate)
IBA
04/2024
1
N(1)-methyl-2-pyridone-5-carboxylic acid
IBA
11/2023
1
5-alpha Reductase Inhibitors
IBA
10/2023
1
PSMA-617
IBA
08/2023
1
Ligands
IBA
08/2023
1
Transferases
IBA
08/2023
1
antiarrhythmic peptide (AAP)
IBA
04/2023
1
Radium-223
IBA
12/2022
1
(18)F-PSMA-11
IBA
11/2022
1
isopropyl cyanoacrylate
IBA
11/2022
1
Elements
IBA
04/2022
1
177Lu-PSMA-617
IBA
01/2022
Therapy/Procedure
131
Prostatectomy (Retropubic Prostatectomy)
03/2024 - 02/2012
79
Therapeutics
04/2024 - 08/2013
52
Lymph Node Excision (Lymph Node Dissection)
12/2023 - 01/2014
45
Radiotherapy
04/2024 - 12/2013
33
Cystectomy
10/2023 - 01/2014
15
Castration
04/2024 - 09/2018
13
Drug Therapy (Chemotherapy)
03/2024 - 04/2014
6
Combined Modality Therapy
03/2024 - 03/2014
6
Length of Stay
12/2023 - 05/2014
6
Adjuvant Radiotherapy
11/2022 - 12/2014
6
Blood Transfusion (Blood Transfusions)
11/2021 - 05/2014
6
Nephrectomy
03/2018 - 01/2014
5
Immunotherapy
04/2024 - 01/2020
5
Robotic Surgical Procedures
10/2022 - 01/2017
4
Transurethral Resection of Bladder
03/2024 - 09/2015
4
Salvage Therapy
02/2024 - 01/2020
4
Orchiectomy (Orchidectomy)
12/2019 - 12/2014
3
Brachytherapy
12/2023 - 11/2021
3
Neoadjuvant Therapy
10/2023 - 09/2014
3
Nephroureterectomy
01/2022 - 03/2014
3
Precision Medicine
12/2020 - 08/2014
3
Patient Readmission
01/2017 - 12/2014
2
Cryotherapy (Therapy, Cold)
08/2023 - 09/2021
2
Palliative Care (Palliative Therapy)
07/2023 - 01/2020
2
Operative Surgical Procedures
11/2022 - 01/2018
2
Solid-State Lasers
11/2021 - 01/2017
2
Adjuvant Chemotherapy
06/2021 - 04/2017
2
Catheters
03/2018 - 01/2016
2
Stents
01/2018 - 03/2015
1
Operative Time
12/2023
1
Cryosurgery
08/2023
1
Conservative Treatment
07/2023
1
Kidney Transplantation
03/2023
1
Metastasectomy
01/2023
1
Aftercare (After-Treatment)
01/2022